10-Q: AquaBounty Technologies Reports Q1 2024 Results Amidst Strategic Shift and Financial Challenges

AquaBounty Technologies reported a net loss of $11.2 million for the first quarter of 2024, while also initiating a sale process for its Indiana farm and securing a new loan to address working capital needs.

Summary

• AquaBounty Technologies reported a net loss of $11.2 million for the first quarter of 2024, compared to a $6.5 million loss in the same period last year.
• The company's product revenue increased to $477,000, up from $398,000 in Q1 2023, primarily due to increased sales of conventional Atlantic salmon, fry, and eggs.
• Product costs rose to $4.5 million, up from $3.6 million in Q1 2023, due to costs associated with winding down operations at the Indiana farm, including a $1 million inventory adjustment.
• The company incurred a $4.3 million non-cash impairment charge related to long-lived assets at its Indiana farm, which is now being prepared for sale.
• AquaBounty's cash and cash equivalents stood at $3.6 million as of March 31, 2024, raising concerns about its ability to continue as a going concern.
• The company secured a $10 million loan in April 2024, with $5 million advanced initially, to address working capital needs and pay off existing debt.
• Construction of the Ohio farm is approximately 30% complete but has been paused due to financing challenges.
• The company is exploring various funding and strategic alternatives, including debt financing, joint ventures, and the sale of its Indiana farm.

Sentiment

Score: 3

Explanation: The document indicates significant financial challenges, including increased losses, a low cash position, and the need for additional capital. The company's ability to continue as a going concern is in doubt, and the impairment charge on assets is a major negative. While there are some positives, such as increased revenue and a new loan, the overall sentiment is negative.

Positives

• Product revenue increased by 20% year-over-year, indicating some growth in sales.
• The company secured a $10 million loan to address immediate working capital needs.
• The company is actively pursuing strategic alternatives to improve its financial position.
• Harvest volume of GE Atlantic salmon increased significantly compared to the same period last year.

Negatives

• The company experienced a significant increase in net loss, from $6.5 million in Q1 2023 to $11.2 million in Q1 2024.
• Product costs increased due to the winding down of operations at the Indiana farm and inventory adjustments.
• A $4.3 million non-cash impairment charge was recorded, reflecting a decrease in the value of assets at the Indiana farm.
• The company's cash position is low, raising substantial doubt about its ability to continue as a going concern.
• Construction of the Ohio farm has been paused due to financing challenges.
• The company is facing significant financial challenges and requires additional capital to continue operations.

Risks

• The company has a history of net losses and expects to incur future losses.
• There is substantial doubt about the company's ability to continue as a going concern due to its low cash balance.
• The company's ability to raise additional capital is uncertain.
• The company faces risks related to the construction and operation of its farms, including delays and cost overruns.
• The company is subject to risks related to the acceptance of its genetically engineered salmon product.
• The company is exposed to risks related to inflation, which is increasing operating costs.
• The company is dependent on third parties for the processing, distribution, and sale of its products.
• The company is subject to various regulatory risks and legal proceedings.

Future Outlook

The company expects to continue to incur losses and requires additional financing to fund its operations and execute its business plan. The company is exploring various funding and strategic alternatives, including the sale of its Indiana farm, debt financing, and potential joint ventures.

Management Comments

• The company believes it is a distinctive brand in land-based aquaculture, leveraging technology to address food insecurity and climate change.
• Management is pursuing a growth strategy that includes the construction of large-scale recirculating aquaculture system farms.
• The company is actively engaged in genetic, genomic, fish health, and fish nutrition research.
• The company is experiencing higher costs due to inflation, impacting all areas of its business.
• The company is working to secure new financing to provide liquidity and fund the construction of its Ohio farm.

Industry Context

The company operates in the land-based aquaculture industry, which is gaining attention as a sustainable alternative to traditional sea-cage farming. The company's genetically engineered salmon product is a unique offering in the market, but it faces challenges related to consumer acceptance and regulatory approvals. The company's financial difficulties highlight the capital-intensive nature of the industry and the risks associated with scaling up operations.

Comparison to Industry Standards

• AquaBounty's financial performance is significantly below industry standards for profitability, as many aquaculture companies are either profitable or have a clear path to profitability.
• Compared to companies like Mowi and Bakkafrost, which are established players in the salmon farming industry, AquaBounty's revenue is very low, and its losses are substantial.
• Other land-based aquaculture companies, such as Atlantic Sapphire, have also faced challenges in scaling up production and achieving profitability, indicating the inherent risks in this sector.
• The impairment charge on the Indiana farm assets is a significant negative indicator, suggesting that the company's assets may not be as valuable as previously thought.
• The company's reliance on debt financing and the need for additional capital raise concerns about its long-term financial viability.

Stakeholder Impact

• Shareholders face significant risk due to the company's financial challenges and the potential for dilution.
• Employees may be affected by potential cost-cutting measures or changes in operations.
• Customers may experience disruptions in supply due to the company's financial difficulties.
• Suppliers may face increased risk of non-payment due to the company's financial instability.
• Creditors face increased risk of default due to the company's financial challenges.

Next Steps

• The company will continue to pursue the sale of its Indiana farm.
• The company will seek additional financing to fund its operations and the construction of its Ohio farm.
• The company will explore potential joint venture partnerships and other strategic transactions.
• The company will continue to monitor and manage its operating costs.

Key Dates

Keywords

AquaBounty, genetically engineered salmon, aquaculture, financial results, net loss, product revenue, farm sale, capital raise, going concern, loan, impairment, Ohio farm, Indiana farm